Scientists from the RCG team are among the recipients of research grants awarded by the Neuroendocrine Tumor Research Foundation (NETRF), announced on 16 February.  Matthieu Foll, Lynnette Fernandez-Cuesta, and their co-investigators in the “Reconciling lung carcinoids histopathological and molecular classifications” project were chosen to receive the funding through a competitive and rigorous peer-review process. This research is part of the lungNENomics project, and builds on Lynnette Fernandez-Cuesta’s NETRF investigator award in 2020. The Rare Cancers Genomics initiative is grateful of the continuous support of NETRF! 

Read the NETRF press release and IARC press release

More details about the project is available here: https://netrf.org/research/reconciling-lung-carcinoids-histopathological-and-molecular-classifications/